台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    70.1
  • 漲跌
    ▼0.2
  • 漲幅
    -0.28%
  • 成交量
    109
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-第一金-安和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-安和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2300.000.163.0068.00-0.1256-0.04%
2024/04/09166.0000.0064.5012530.39%
2024/04/0800.00367.1068.90-3251-1.19%
2024/04/0200.00469.5569.70-4248-1.61%
2024/04/01169.00569.3069.90-4247-1.62%
2024/03/280.168.70369.0769.50-2.9244-1.19%
2024/03/27569.8800.0069.0052442.04%
2024/03/260.570.0000.0069.300.52410.21%
2024/03/25269.9000.0069.8022370.84%
2024/03/22363.90462.3064.30-1230-0.43%
2024/03/13258.80256.8557.4002260.00%
2024/03/12260.2500.0059.9022220.90%
2024/03/111061.5400.0061.40102184.58%
2024/03/080.360.0035.459.6861.00-35.1214-16.34%
2024/03/07164.00365.5764.50-2209-0.96%
2024/03/062.465.29364.3765.90-0.7206-0.32%
2024/03/051363.85363.0064.00102004.99%
2024/03/041356.97157.1060.20121936.20%
2024/03/011153.5600.0054.80111835.99%
2024/02/29554.6000.0054.6051802.77%
2024/02/22450.8000.0051.1041822.19%
2024/02/201452.5600.0048.30141807.74%
2024/02/192853.8700.0052.502818415.20%
2024/02/16453.0000.0052.0041832.18%
2024/02/151155.4500.0055.50111776.19%
2024/02/0500.00349.7550.50-3164-1.82%
2023/12/010.540.0000.0040.000.52100.24%
2023/11/301.540.9000.0041.101.52050.73%
2023/11/16237.6000.0039.3021751.14%
2023/11/15135.9500.0036.4511630.61%
2023/11/01128.5000.0028.8011360.73%
2022/09/0200.0009.9510.0501200.00%
2022/08/2200.0009.949.9401200.00%
2022/06/2800.000.112.6012.65-0.1159-0.07%
2021/11/1600.00115.4515.40-181-1.23%
2021/11/1200.00115.6515.45-182-1.22%
2021/11/11216.3500.0016.002822.44%
2021/06/1600.00216.6016.45-2477-0.42%
2021/06/1100.00216.5016.90-2477-0.42%
2021/05/2500.00116.6016.55-1531-0.19%
2021/05/21116.8500.0016.7015470.18%
2021/05/14419.5500.0017.9044590.87%
2020/09/1500.00518.7019.15-51,377-0.36%
2020/09/1400.00518.2518.25-51,395-0.36%
2020/09/0900.00119.5019.40-11,564-0.06%
2020/09/0400.00219.3519.40-21,809-0.11%
2020/08/2100.00120.5021.15-12,047-0.05%
2020/08/1400.00123.4022.90-12,307-0.04%
2020/08/1200.000.223.7023.80-0.22,327-0.01%
2020/07/3000.00325.1525.25-32,272-0.13%
2020/07/2900.00124.5525.55-12,273-0.04%
2020/07/2700.00125.7024.90-12,248-0.04%
2020/07/2200.00129.5030.00-12,204-0.05%
2020/07/21526.0600.0027.4552,1490.23%
2020/07/2000.001024.3225.00-102,109-0.47%
2020/07/17326.1500.0026.1532,0680.15%
2020/07/15629.281230.7030.80-61,983-0.30%
2020/07/14932.231330.9829.60-41,907-0.21%
2020/07/132031.50131.0031.55191,7931.06%
2020/07/10728.532028.0028.70-131,666-0.78%
2020/07/0800.00123.7523.75-11,516-0.07%
2020/07/0700.00321.4721.60-31,505-0.20%
2020/06/17126.0000.0025.3511,3500.07%
2020/06/15623.8700.0024.2061,2070.50%
2020/06/12121.0000.0022.0011,1240.09%
2020/06/11220.35120.2021.0011,0770.09%
2020/06/09117.5500.0017.4019580.10%
2020/06/0200.00116.7516.60-1966-0.10%
2020/05/28119.40217.6818.50-1978-0.10%
2020/05/27119.4500.0019.4519470.11%
2020/05/22117.7000.0017.9019300.11%
2020/05/13112.2000.0012.1517860.13%
2019/12/270.29.9900.009.900.2690.33%
2018/04/1600.00221.4521.35-2329-0.61%
2018/04/13224.0000.0023.7023020.66%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音